Mouthwash developed by Mahidol Uni can kill coronavirus in the mouth

The faculties of Dentistry and Tropical Medicine at Thailand’s Mahidol University claim to have jointly developed a mouthwash formula which is 99% effective at killing the COVID-19 virus in the…

Read More

Human trials of Thailand’s ChulaCov19 mRNA vaccine show promising results

The mRNA vaccine, currently being developed by the Vaccine Research Centre of the Faculty of Medicine of Chulalongkorn University, can stimulate the immune system to produce killer T-cells which can…

Read More

Human trials of Thailand’s first COVID protein subunit vaccine to begin in September

The first phase of human trials of a COVID-19 protein subunit vaccine, jointly developed by the Vaccine Research Centre of Chulalongkorn University and Baiya Phytopharm Company, will be launched in…

Read More
A patient receives a nasal spray vaccine for the H1N1 virus in Maryland in 2009. AFP PHOTO / Tim Sloan (Photo by TIM SLOAN / AFP)

Two nasal spray COVID-19 vaccines under development by Thailand’s BIOTEC

Thai virologists, at the National Centre for Genetic Engineering and Biotechnology (BIOTEC), have been developing two candidate nasal spray vaccines, or vaccine inhalers, which they hope will provide an option…

Read More

Chula Uni recruiting 174 volunteers for human trials of its COVID-19 vaccine

Thailand’s Chulalongkorn University’s Centre of Excellence in Vaccine Research and Development is recruiting 174 volunteers for human trials of its vaccine, known as ChulaCov19, scheduled to start at the end…

Read More
(File) Thailand’s Public Health Minister Anutin Charnvirakul

Thailand to start human trials of locally developed COVID-19 vaccine in March

Thailand will begin the first stage of human trials in March of a new COVID-19 vaccine, which has been developed jointly by the Faculty of Tropical Medicine of Mahidol University…

Read More

Thailand’s Chulalongkorn Uni to begin human trials of its mRNA vaccine in April

Chulalongkorn University’s vaccine research centre will start human trials of its mRNA vaccine candidate, tentatively in April, after it received prototype vaccine from two factories in California. The centre’s director,…

Read More
In this handout photo released by the University of Oxford blood samples from coronavirus vaccine trials are handled inside the Jenner Institute in Oxford, England Thursday June 25, 2020. Scientists at Oxford University say their experimental coronavirus vaccine has been shown in an early trial to prompt a protective immune response in hundreds of people who got the shot. In research published Monday July 20, 2020 in the journal Lancet, scientists said that they found their experimental COVID-19 vaccine produced a dual immune response in people aged 18 to 55. (John Cairns, University of Oxford via AP)

COVID-19 vaccines expected next year at about 620 baht per dose

The first anti-COVID-19 vaccines are expected to be available for use in humans next year, at an estimated cost of 620 baht per dose, said Dr. Siriroek Songsivilai, secretary-general of…

Read More

Page 1 of 1

Login

Welcome! Login in to your account

Remember me Lost your password?

Lost Password